QUEBEC CITY, Feb. 22, 2024 /CNW/ - Following its successful introduction into several hospitals across its home province, Quebec-based OxyNov is releasing its technology on the Canadian market. As ...

The sector’s expansion is attributed to the growing demand for home oxygen therapy for chronic respiratory diseases. By ...

As global awareness around respiratory health continues to rise, the market for portable oxygen concentrators (POCs) is ...

Inogen is up almost 10% on news that it received FDA clearance for its latest home oxygen concentrator. Later this year, the company expects to start selling the device, which it has dubbed the ...

The global high flow oxygen therapy devices market is anticipated to witness moderate growth, rising from USD 1.3 billion in 2025 to USD 1.6 billion by 2035 at a CAGR of 2.1% over the forecast period.

With a new CEO in place and its revenues on the rebound after a tumultuous 2020, Inogen is looking to make its product line of at-home and portable oxygen concentrators bigger and ...

It stops the flow of oxygen should the tubing catch fire. Officials recommend having two of these on every oxygen line. It isn’t expensive, ranging anywhere from $4 to $7 apiece.

The Global Oxygen Conservation Devices Market is expected to grow at a CAGR of approximately 12% over the forecast period and is experiencing significant growth, driven by the increasing prevalence of ...

The Noccarc H210 addresses the pressing need for high flow oxygen therapy devices in the country owing to the current pandemic and the rising cases of COVID-19 patients. The HFOT (High-Flow Oxygen ...

The consequences are dire for the health of a premature baby - too much oxygen can cause blindness, and too little oxygen can cause brain damage and other negative health effects.

Clinical trial testing automatic oxygen control device for premature infants The innovative device, designed by a researcher at the MU College of Engineering, will be tested at MU Women’s and ...